Literature DB >> 29666799

Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.

Harushi Udagawa1, Masaki Ueno1.   

Abstract

The latest 8th edition of TNM Classification of Malignant Tumours by Union for International Cancer Control (UICC) and 11th edition of Japanese Classification of Esophageal Cancer by Japan Esophageal Society (JES) are the two major classifications widely accepted as tools for clinical staging of esophageal cancer. Both systems consist of three main categories, i.e., T, N, and M, but large difference exists between the two. JES system has more detailed sub-classification of T1 tumors reflecting meticulous work by Japanese investigators on superficial esophageal cancer. N-category shows the largest difference. UICC defines the N-category according to only the number of the metastatic regional lymph nodes. The definition of regional nodes in UICC system is static and uniform, and supraclavicular nodes are definitely excluded. In JES system, regional nodes are subgrouped into five different patterns according to the main tumor location, and the supraclavicular nodes are always regional nodes for thoracic esophageal cancer. Japanese surgeons have described the evidence that regional nodes should be dynamically defined according to tumor location and supraclavicular nodes should be included in regional nodes. Compared to the simplified N-category, the staging matrix of UICC system is somewhat complicated. The clinical stage and pathological stage of UICC system are not identical and difference exists also between squamous cell carcinoma (SCC) and adenocarcinoma. It has another system of pathological prognostic grouping. We can imagine several reasons for the difference occurred between the two systems. One is the difference of major pathology. Another reason is the difference of basic concept of cancer treatment. The relative "dependence" on radical surgery in Japan has required the detailed definition of each lymph node station and the evaluation of "efficacy index" of each station. The strict and detailed definition of lymph node stations has been regarded as an obstacle to those who are not familiar with it. Some simplification can be done but maintaining dynamic definition of regional lymph nodes linked to tumor location. If UICC system can accept this concept, I think the two systems can be unified to realize more practical and useful staging system as an international common language.

Entities:  

Keywords:  Japan Esophageal Society (JES); Union for International Cancer Control (UICC); staging of esophageal cancer; supraclavicular lymph nodes

Year:  2018        PMID: 29666799      PMCID: PMC5890035          DOI: 10.21037/atm.2018.01.27

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  33 in total

1.  Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Surg Endosc       Date:  2009-12-24       Impact factor: 4.584

2.  Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy.

Authors:  Feng Wang; Yuzhen Zheng; Zhen Wang; Qingfeng Zheng; Qingyuan Huang; Shuoyan Liu
Journal:  Ann Thorac Surg       Date:  2017-06-29       Impact factor: 4.330

3.  Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer.

Authors:  Yuji Tachimori; Soji Ozawa; Hodaka Numasaki; Hisahiro Matsubara; Masayuki Shinoda; Yasushi Toh; Harushi Udagawa
Journal:  J Thorac Cardiovasc Surg       Date:  2014-02-10       Impact factor: 5.209

Review 4.  Pattern of lymph node metastases of squamous cell esophageal cancer based on the anatomical lymphatic drainage system: efficacy of lymph node dissection according to tumor location.

Authors:  Yuji Tachimori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  T W Rice; H Ishwaran; W L Hofstetter; D P Kelsen; C Apperson-Hansen; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

6.  Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  Thomas W Rice; Hemant Ishwaran; Eugene H Blackstone; Wayne L Hofstetter; David P Kelsen; Carolyn Apperson-Hansen
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

7.  The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Junko Takita; Hitoshi Kimura; Ahmad Faried; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Hiroyuki Kuwano; Noboru Oriuchi; Keigo Endo
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

8.  Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial.

Authors:  Tomoya Yokota; Hiroyasu Igaki; Ken Kato; Yasuhiro Tsubosa; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Haruhiko Fukuda; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2015-09-03       Impact factor: 3.402

9.  Japanese Classification of Esophageal Cancer, 11th Edition: part II and III.

Authors: 
Journal:  Esophagus       Date:  2016-11-10       Impact factor: 4.230

10.  Japanese Classification of Esophageal Cancer, 11th Edition: part I.

Authors: 
Journal:  Esophagus       Date:  2016-11-10       Impact factor: 4.230

View more
  6 in total

1.  Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer?

Authors:  Ran Mo; Chen Chen; Liang Pan; Ao Yu; Dongjin Wang; Tao Wang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer.

Authors:  Harushi Udagawa
Journal:  Ann Gastroenterol Surg       Date:  2020-05-14

3.  Should the clinical significance of supraclavicular and celiac lymph node metastasis in thoracic esophageal cancer be reevaluated?

Authors:  Junmiao Wen; Donglai Chen; Ting Zhao; Jiayan Chen; Yuhuan Zhao; Di Liu; Wenjia Wang; Xinyan Xu; Min Fan; Chang Chen; Yongbing Chen
Journal:  Thorac Cancer       Date:  2019-07-10       Impact factor: 3.500

4.  Predicting aggressive histopathological features in esophageal cancer with positron emission tomography using a deep convolutional neural network.

Authors:  Joe Chao-Yuan Yeh; Wei-Hsiang Yu; Cheng-Kun Yang; Ling-I Chien; Ko-Han Lin; Wen-Sheng Huang; Po-Kuei Hsu
Journal:  Ann Transl Med       Date:  2021-01

5.  Ideal Anatomical Landmark Points for Thoracic Esophagus Segmentation in the Chinese Population.

Authors:  Di Lu; Xiuyu Ji; Jintao Zhan; Jianxue Zhai; Tingxiao Fang; Siyang Feng; Xiguang Liu; Lin Yu; Zhiming Chen; Zhizhi Wang; Xuanzhen Wu; Sue Liu; Hua Wu; Kaican Cai
Journal:  Front Surg       Date:  2021-12-14

6.  SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway.

Authors:  Chunhong Ren; Zhengbo Zhou; Xiuzhen Wang; Xu Hua; Muping Zou; Xin Zhang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.